Stablix
Anna Kaplan is a Senior Scientist II at Stablix, Inc., having previously held senior scientist roles at 858 Therapeutics and Gotham Therapeutics. Prior to their industry experience, Anna worked as a Postdoctoral Research Scientist at Columbia University, where Anna conducted experiments leading to important discoveries in Alzheimer's disease and cancer research. Anna also has experience as a biochemistry tutor and graduate teaching assistant. Anna holds a Ph.D. in Chemical Biology from Columbia University, along with a Master of Philosophy in Biological Sciences and a Bachelor of Science in Biology and Biochemistry from Brandeis University.
Stablix
Stablix is pioneering an entirely new field of targeted protein stabilization (TPS) to bring transformative medicines to patients with unmet medical need.